It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2004.
2004 | Mumbai, Maharashtra, India | ActiveSundaram Pharma Private Limited, a active private limited company, was established on 09 November 2004 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397MH2004PTC149475. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.
Its leadership includes Dhroov Dinesh Singh (Director), Dinesh Amar Bahadur Singh (Director), Brijesh Amar Bahadur Singh (Director). Past directors included Dhroov Dinesh Singh, Ganpat Ramlakhan Gupta, Dinesh Amar Bahadur Singh. It holds ₹8.49 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4/6 Laxmi Bhuvanbora Bazar Street Fort, Mumbai, Maharashtra, 400001.
U51397MH2004PTC149475
149475
09 November 2004
₹1.00 M
₹0.15 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sundaram Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhroov Dinesh Singh | Director | 15 Mar 2022 | Current |
| Dinesh Amar Bahadur Singh | Director | 01 May 2023 | Current |
| Brijesh Amar Bahadur Singh | Director | 09 Nov 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 14 Mar 2023 | Past |
| Pramod Abcsdd | Additional Director | 15 Mar 2022 | Past |
| Pramod Abcsdd | Director | 04 Jun 2021 | Past |
| Pramod Abcsdd | Director | 04 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sundaram Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 114.03% increase. The company also saw a substantial improvement in profitability, with a 243.7% increase in profit. The company's net worth Soared by an impressive increase of 78.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sundaram Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹84,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2025 | Others | ₹4.99 Cr | Open |
| 08 Apr 2024 | Others | ₹3.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sundaram Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sundaram Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundaram Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 49.90 M with Charge ID 101114365 was registered on 30 May 2025. was completed.
Progress on Sundaram Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others amounted to Rs. 35.00 M with Charge ID 100925143 was registered on 08 Apr 2024. was documented.
The activity Sundaram Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Dinesh Amar Bahadur Singh was appointed as a Director was appointed as a Director on 01 May 2023 & has been associated with this company since 2 years 6 months . was documented.
Dhroov Dinesh Singh was appointed as a Director was appointed as a Director on 15 Mar 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
The CIN of Sundaram Pharma Private Limited is U51397MH2004PTC149475.
Sundaram Pharma Private Limited is headquartered at 4/6 Laxmi Bhuvanbora Bazar Street Fort, Mumbai, Maharashtra, 400001.
Sundaram Pharma Private Limited was incorporated on 09 November 2004.
The current directors of Sundaram Pharma Private Limited are
The primary industry of Sundaram Pharma Private Limited is Trade.
Sundaram Pharma Private Limited is unlisted.
The authorized capital of Sundaram Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX